Pluristem Therapeutics Inc (PSTI)

[SrdghJack]

I’m starting to think that if really good news was imminent, the run up to $2 would not have fallen back towards $1.70.

Regarding Lonza, I think that would be amazing to have a deal with them. Win-win. I have also wondered why we took 2 years to build a facility that can only make 150k doses, and then not even have them operating to make money when this company clearly needs it. Shoot, that money could have maybe funded a trial, or the building of a larger facility. The new facility in Haifa and its director’s connection to Pluristem is interesting though. We can only hope.

Still no news from Japan in a partnership, trial, or Fukushima results. Nothing has come out and has been stagnant for quite some time.

We also have not yet seen any human data for R18, which would come out of the Phase I trial in HCT. Not have we heard from the NYBC.

Looking back at the previous presentations they’ve put out this year, it reads like nothing more than a list of broken promises. We keep planting seeds but have yet to see a tree. No product approval, no partnership, no contracts or sales, no revenue. Still just one giant research project and if we don’t get off the ground soon I could see this 10 year research project owned by someone else.